Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses
- PMID: 32598242
- DOI: 10.1089/gtmb.2020.0047
Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses
Abstract
Background: Inflammatory breast cancer (IBC) is a rare type of breast cancer with poor prognoses, moreover its pathogenesis is not entirely clear. The aim of this study was to identify key genes of IBC, which might serve as diagnostic biomarkers and/or therapeutic targets. Methods: Two microarray datasets, GSE23720 and GSE45581, were obtained from the Gene Expression Omnibus database, and a differential expression analysis was performed. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to understand the potential biological functions of the differentially expressed genes (DEGs). Next, a protein-protein interaction (PPI) network was constructed and visualized by Cytoscape. Functional modules and hub genes were screened using MCODE and cytohubba plug-ins, and the Cancer Genome Atlas survival analysis along with quantitative reverse transcriptional polymerase chain reactions of clinical samples was used to validate the effect that the hub genes have on IBC. Results: A total of 215 DEGs were identified, consisting of 105 upregulated and 110 downregulated genes. GO and KEGG analyses showed that the enriched terms and pathways were mainly associated with cell cycle, proliferation, drug metabolism, and oncogenesis. From the PPI network, we identified six hub genes, including Cell Division Cycle 45 (CDC45), Polo Like Kinase 1 (PLK1), BUB1 Mitotic Checkpoint Serine/Threonine Kinase B (BUB1B), Cell Division Cycle 20 (CDC20), Aurora Kinase A (AURKA), and Mitotic Arrest Deficient 2 Like 1 (MAD2L1). The survival analyses and expression validation studies verified the robustness of these hub genes. Conclusion: This study provides new insights into the understanding of the molecular mechanisms of IBC; in addition, the identified hub genes may serve as potential targets for diagnosis and treatment.
Keywords: GEO; bioinformatics; expression profiling; inflammatory breast cancer.
Similar articles
-
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.J Ovarian Res. 2020 Jan 27;13(1):10. doi: 10.1186/s13048-020-0613-2. J Ovarian Res. 2020. PMID: 31987036 Free PMC article.
-
Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.Med Sci Monit. 2018 Sep 14;24:6438-6448. doi: 10.12659/MSM.910088. Med Sci Monit. 2018. PMID: 30213925 Free PMC article.
-
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29. Mol Med Rep. 2018. PMID: 29845250 Free PMC article.
-
Exploring nasopharyngeal carcinoma genetics: Bioinformatics insights into pathways and gene associations.Med J Malaysia. 2024 Sep;79(5):615-625. Med J Malaysia. 2024. PMID: 39352166 Review.
-
STAT4 and COL1A2 are potential diagnostic biomarkers and therapeutic targets for heart failure comorbided with depression.Brain Res Bull. 2022 Jun 15;184:68-75. doi: 10.1016/j.brainresbull.2022.03.014. Epub 2022 Mar 31. Brain Res Bull. 2022. PMID: 35367598 Review.
Cited by
-
Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis.Blood Res. 2024 Feb 19;59(1):4. doi: 10.1007/s44313-024-00002-0. Blood Res. 2024. PMID: 38485838 Free PMC article.
-
Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.Medicina (Kaunas). 2023 Sep 24;59(10):1705. doi: 10.3390/medicina59101705. Medicina (Kaunas). 2023. PMID: 37893423 Free PMC article.
-
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target.Breast. 2023 Jun;69:476-480. doi: 10.1016/j.breast.2023.01.010. Epub 2023 Jan 25. Breast. 2023. PMID: 36717329 Free PMC article.
-
PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma.Biomed Res Int. 2022 Jul 30;2022:7848771. doi: 10.1155/2022/7848771. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Jun 21;2023:9846745. doi: 10.1155/2023/9846745. PMID: 35941968 Free PMC article. Retracted.
-
Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers.Breast Cancer Res Treat. 2022 Jun;193(2):361-379. doi: 10.1007/s10549-022-06567-7. Epub 2022 Mar 29. Breast Cancer Res Treat. 2022. PMID: 35348974
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous